Your browser doesn't support javascript.
loading
Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia.
Lewis, Gary F; Hegele, Robert A.
Affiliation
  • Lewis GF; Department of Medicine and Department of Physiology, Division of Endocrinology and Metabolism, Banting and Best Diabetes Centre, University of Toronto, Toronto, ON, Canada; Department of Medicine, Toronto General Hospital, Toronto, ON, Canada. Electronic address: gary.lewis@uhn.ca.
  • Hegele RA; Department of Medicine, Department of Biochemistry, and The Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Lancet Diabetes Endocrinol ; 10(2): 142-148, 2022 02.
Article in En | MEDLINE | ID: mdl-34922644
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hypertriglyceridemia / Metabolic Syndrome / Atherosclerosis Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2022 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hypertriglyceridemia / Metabolic Syndrome / Atherosclerosis Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Diabetes Endocrinol Year: 2022 Document type: Article Country of publication: United kingdom